rifampin and Gaucher-Disease

rifampin has been researched along with Gaucher-Disease* in 3 studies

Other Studies

3 other study(ies) available for rifampin and Gaucher-Disease

ArticleYear
Pleural tuberculosis in a patient with untreated type 1 Gaucher disease.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:1

    Gaucher disease (GD) is an autosomal recessive glycolipid storage disorder, due to deficiency of the lysosomal enzyme glucocerebrosidase, leading to accumulation of the substrate glucocerebroside in the cells of the macrophage-monocyte system. Patients with GD have alteration in their immune system and impaired microbicidal capacity of mononuclear phagocytes. It has also been demonstrated that monocyte dysfunction may correlate with the plasma glucocerebrosidase concentrations. Tuberculosis (TB) is a major public health problem in developing countries. Pleural TB is one of the most common forms of extra-pulmonary TB. Since immune system can be impaired due to the deficiency of glucocerebrosidase in various ways, TB can be observed in patients with GD especially when left untreated. Cytopenia(s) is also general finding in untreated Gaucher patients, and they may be observed most frequently due to the infiltration of the bone marrow with Gaucher cells together with the additional factor of splenomegaly. We herein present a case of an adult patient with heterozygous untreated GD1, who developed pleural TB complicated by ipsilateral pulmonary fibrosis. Before his admission to our clinic, pleurectomy operation was performed and 4-drug combination anti-TB therapy was initiated including isoniazid, rifampicin, ethambutol and pyrazinamide. Fever complaint was disappeared with anti-TB treatment but he also had fatigue and pain. After initiation of enzyme replacement therapy in addition to anti-TB treatment, clinical and hematological improvement was observed. To our knowledge, this is the first reported case of GD1 with pleural TB.

    Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Gaucher Disease; Humans; Isoniazid; Male; Pulmonary Fibrosis; Pyrazinamide; Rifampin; Tuberculosis, Pleural; Turkey

2016
Doxycycline and rifampin could be useful therapeutic agents for Gaucher disease.
    Molecular genetics and metabolism, 2007, Volume: 90, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Doxycycline; Gaucher Disease; Humans; Male; Rifampin

2007
Gaucher disease and brucella: just a mere coincidence?
    Genetic counseling (Geneva, Switzerland), 2003, Volume: 14, Issue:3

    Gaucher disease type I and brucellosis are chronic diseases with similar symptoms and physical signs though the former is the most common lysosomal storage disease and the latter is an infectious disease. The similarities between these diseases make differential diagnosis difficult. Immunodeficiency is a feature of Gaucher disease type I and increases the susceptibility towards infections. A Gaucher disease type I patient with brucellosis is presented with improvement after treatment of brucellosis.

    Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Brucellosis; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Gaucher Disease; Humans; Magnetic Resonance Imaging; Male; Rifampin; Spleen

2003